Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.1100 (1.08%) ($42.1100 - $42.1100) on Wed. Jul. 19, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 86 | Latest Price | $42.1100(1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.5% a day on average for past five trading days. | Weekly Trend | HALO advances 6.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) BNDX(36%) IBB(33%) XBI(33%) IGOV(30%) BLOK(29%) | Factors Impacting HALO price | HALO will decline at least -1.4% in a week (0% probabilities). INDA(-23%) TBT(-21%) UUP(-13%) XLRE(-9%) EWY(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.32(4.44%) | 10 Day Moving Average | $38.76(8.64%) | 20 Day Moving Average | $37.12(13.44%) | To recent high | 0% | To recent low | 39.6% | Market Cap | $5.755b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |